GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population

作者: Rayjean J. Hung , Paolo Boffetta , Paul Brennan , Christian Malaveille , Agnès Hautefeuille

DOI: 10.1002/IJC.20157

关键词:

摘要: Tobacco smoking and occupation are major risk factors of bladder cancer via exposure to polycyclic aromatic hydrocarbons (PAHs) amines. Glutathione S-transferase (GST) M1, T1 P1 involved in the detoxification PAH reactive metabolites. Two N-acetyltransferase isozymes, NAT2 NAT1, have roles catalyzing N-acetylation O-acetylation Cytochrome p450 1B1 (CYP1B1) sulfotransferase 1A1 (SULT1A1) also metabolism PAHs It is hypothesized that genetic polymorphisms these metabolic enzymes an effect on individual susceptibility particular by interacting with relevant environmental exposures. A hospital-based case-control study among men Brescia, Northern Italy recruited 201 incidence cases 214 controls from 1997-2000. Occupational exposures were blindly coded occupational physicians. Genotyping carried out PCR-RFLP method. Unconditional multivariate logistic regression was applied model association between risk. Effect modifications age onset, amines evaluated. We conducted analysis interaction factors. GSTM1 GSTT1 null genotype associated increased odds ratio (OR) 1.69 (95% confidence interval [CI] = 1.11-2.56) 1.74 CI 1.02-2.95), respectively. The seen particularly heavy smokers, there a combined (OR 2.77, 95% 1.08-7.10). observed trend (p-value < 0.01) increasing comparing subjects normal activity one 1.82, 1.16-2.85) or both genotypes 2.58, 1.27-5.23). slow acetylator marginally 1.50, 0.99-2.27), OR for joint 3.26 1.06-9.95). SULT1A1 Arg213His polymorphism showed marginal protective effect. These findings suggest may be modulated GSTM1, polymorphisms.

参考文章(61)
Jordi To-Figueras, Manel Gené, Jesús Gómez-catalán, Esther Piqué, Natividad Borrego, Josep Lluís Carrasco, Josep Ramón, Jacint Corbella, Genetic polymorphism of glutathione S-transferase P1 gene and lung cancer risk. Cancer Causes & Control. ,vol. 10, pp. 65- 70 ,(1999) , 10.1023/A:1008811824890
D. A. Bell, J. A. Taylor, M. A. Butler, E. A. Stephens, J. Wiest, L. H. Brubaker, F. F. Kadlubar, G. W. Lucier, Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis. ,vol. 14, pp. 1689- 1692 ,(1993) , 10.1093/CARCIN/14.8.1689
Hirvonen A, Polymorphic NATs and cancer predisposition. IARC scientific publications. pp. 251- ,(1999)
Strange Rc, Fryer Aa, The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC scientific publications. pp. 231- ,(1999)
Hisato Inatomi, Naoki Nagata, Tetsuro Matsumoto, Toshihiro Kawamoto, Douglas A. Bell, Hideaki Itoh, Sigeru Kaneko, Shin Takasawa, Kunio Ikemura, Takahiko Katoh, Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics. ,vol. 9, pp. 165- 169 ,(1999)
Mark Deakin, Richard C. Strange, Mary Watson, David M. Umbach, Douglas A. Bell, James Elder, Trisha Castranio, Elizabeth A. Stephens, C. Hendrickse, Hamish Duncan, Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Research. ,vol. 55, pp. 3537- 3542 ,(1995)
E. Steliarova-Foucher, M. Laversanne, J. Ferlay, D. Forman, S. Antoni, Freddie Ian Bray, C. Gombe Mbalawa, B. Kohler, M. Piñeros, D. H. Brewster, I. Soerjomataram, R. Swaminathan, Cancer Incidence in Five Continents ,(1997)
Ingolf Cascorbi, Jürgen Brockmöller, Ivar Roots, Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Research. ,vol. 61, pp. 5051- 5056 ,(2001)